The ongoing multidistrict litigation (MDL) for GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, reached a pivotal moment with the filing of a Master Complaint
167 MirA.BoydK
The diurnal, i.e., the daily trend has a sharp rise within 30-60 minutes of waking up and subsequent slow decline throughout the day
Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway
Thyroid dysfunction from antineoplastic agents
To avoid the potential of individuals with type 2 diabetes, diabetes mellitus due to an underlying condition, drug or chemical induced diabetes and any other specified type of diabetes mellitus being included and skewing the analysis, the ICD codes E11, E08, E09 and E13, respectively, were used as exclusion criteria